Karen L. Morejon

Sao Paulo, SP, BR 
Sao Paulo, SP, BR 

Overview

Karen Morejon practices practicing medicine in Sao Paulo, Brazil.

Their clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), COVID-19, and Periodontitis.

They are actively involved in clinical research, co-authoring 13 peer reviewed articles and participating in 2 clinical trials.

Locations

Sao Paulo, SP, Brazil
Other Locations
Ribeirao Preto, SP, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized, Pragmatic, Open Controlled Multicentre Study, Evaluating the Use of Rivaroxaban in Mild or Moderate COVID-19 Patients
Randomized, Pragmatic, Open Controlled Multicentre Study, Evaluating the Use of Rivaroxaban in Mild or Moderate COVID-19 Patients
Enrollment Status: Terminated
Publish Date: January 25, 2023
Intervention Type: Drug
Study Drug: Rivaroxaban
Study Phase: Phase 4
Pragmatic, Double-blind, Placebo-controlled Randomized Clinical Trial, Evaluating Hydroxychloroquine for Prevention of Hospitalization and Respiratory Complications in Non-hospitalized Patients With Confirmed or Probable COVID-19
Pragmatic, Double-blind, Placebo-controlled Randomized Clinical Trial, Evaluating Hydroxychloroquine for Prevention of Hospitalization and Respiratory Complications in Non-hospitalized Patients With Confirmed or Probable COVID-19
Enrollment Status: Completed
Publish Date: March 07, 2022
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 4
View 1 Less Clinical Trial

13 Total Publications

The 2026 FIFA World Cup: Communicable disease risks and advice for visitors to Canada, the United States, and Mexico.
The 2026 FIFA World Cup: Communicable disease risks and advice for visitors to Canada, the United States, and Mexico.
Journal: Travel medicine and infectious disease
Published: May 29, 2026

Frequently Asked Questions about Karen L. Morejon

Is Karen L. Morejon a top-rated expert for Severe Acute Respiratory Syndrome (SARS)?

MediFind is an objective health platform that identifies experts based on real-world data. Karen L. Morejon is classified as an Experienced expert for Severe Acute Respiratory Syndrome (SARS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Karen L. Morejon participate in research or clinical trials?

Yes. Karen L. Morejon has published 13 articles and abstracts on conditions like Severe Acute Respiratory Syndrome (SARS). You can view a list of Karen L. Morejon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Morejon's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile